Bright Harbour Advisory has provided sell-side advice to the shareholders of Severn Healthcare Technologies (“Severn”) on its sale to GBUK, a portfolio company of A&M Capital Europe (“AMCE”). Financial terms of the transaction have not been disclosed.
Founded in 2014, Severn is a leading distributor of single-use medical devices in the fields of ENT, neuro-otology and plastic & reconstructive surgery. Severn has developed strategic partnerships with leading global manufacturers and has become a trusted partner to healthcare professionals within the NHS and private sector through its deep technical expertise and outstanding customer support.
The acquisition represents GBUK’s second acquisition since AMCE’s investment in December 2023. The acquisition is anticipated to strengthen GBUK’s clinical offering while expanding its product presence in new and innovative therapeutic areas.
George Strang, Chairman and co-founder of Severn, said: “Having acquired and sold businesses previously, I knew what I wanted from an adviser. Kristian and his team brought us a fantastic selection of international acquirers which gave us the benefit of choice. Their understanding of PE-backed consolidators was invaluable in helping us retain our independent culture within the new group.”
Kristian Gavan, Partner, who led the Bright Harbour team, commented: “Severn is a classic example of how we can support successful entrepreneurs to find new custodians for their businesses. We uncovered a worldwide audience with an interest in Severn and secured an optimal outcome for its owners.”
For more information or to discuss how we may be able to help you, please contact Kristian Gavan.